Business Model Breakdown
How Healthcare Triangle Inc Makes Money
HCTI
Market Cap
$4M
Annual Revenue
$13M
Profit Margin
-48.9%
The Short Version
Healthcare Triangle Inc. provides specialized cloud, data, and digital transformation solutions to the healthcare and life sciences sectors. They help organizations migrate to cloud platforms, manage data, and build integrated health advisory and care systems. Their revenue is generated through delivering these services, and more recently, through contributions from acquired subsidiaries, such as those in Spain, focusing on health-related platforms and advisory services. The company aims to facilitate technology adoption and data-driven decision-making within the healthcare ecosystem.
Where the Revenue Comes From
Cloud and Data Transformation Services (primary)
Integrated Health Advisory and Care Platforms (from acquisitions)
Who buys: Hospitals, health systems, life sciences companies, and other healthcare organizations.
Why It Works (Competitive Advantages)
- ✔None are currently durable or substantial enough to overcome financial distress.
Economic Moat: None
What Our Analysis Says
DVR Score as of April 30, 2026
Healthcare Triangle Inc. (HCTI) remains in a critical financial state, reinforcing the extremely low score from the previous analysis. While FY2025 revenue grew by 18.8% to $13.9M, this growth is severely undermined by a collapse in gross margin from 24.7% to 13.6%, indicating worsening unit economics. Auditors have raised a 'going concern' warning (April 2026), signaling substantial doubt about the company's ability to survive. Retained earnings are -$43.0M, and substantial share dilution through an ATM program continues. Strategic initiatives like a platform development agreement and Africa market entry are overshadowed by existential financial distress. The market capitalization, explicitly stated as $0.00B in the input (though calculated as ~$2.82M from recent share price in the research), signals near-zero equity value. Without a clear and immediate path to profitability and solvency, 10x growth potential is non-existent, and the risk of total capital loss remains extremely high.